- Home
- EBS vs GEVO Comparison
EBS vs GEVO Comparison
Compare EBS & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- GEVO
- Stock Information
- Founded
- EBS 1998
- GEVO 2005
- Country
- EBS United States
- GEVO United States
- Employees
- EBS N/A
- GEVO N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- GEVO Major Chemicals
- Sector
- EBS Health Care
- GEVO Industrials
- Exchange
- EBS Nasdaq
- GEVO Nasdaq
- Market Cap
- EBS 529.9M
- GEVO 470.1M
- IPO Year
- EBS 2006
- GEVO 2011
- Fundamental
- Price
- EBS $10.93
- GEVO $2.07
- Analyst Decision
- EBS Strong Buy
- GEVO Buy
- Analyst Count
- EBS 1
- GEVO 2
- Target Price
- EBS $15.00
- GEVO $8.13
- AVG Volume (30 Days)
- EBS 1.5M
- GEVO 3.9M
- Earning Date
- EBS 10-29-2025
- GEVO 11-10-2025
- Dividend Yield
- EBS N/A
- GEVO N/A
- EPS Growth
- EBS N/A
- GEVO N/A
- EPS
- EBS 1.35
- GEVO N/A
- Revenue
- EBS $788,900,000.00
- GEVO $120,932,000.00
- Revenue This Year
- EBS N/A
- GEVO $909.99
- Revenue Next Year
- EBS $15.42
- GEVO $11.14
- P/E Ratio
- EBS $8.11
- GEVO N/A
- Revenue Growth
- EBS N/A
- GEVO 675.75
- 52 Week Low
- EBS $4.02
- GEVO $0.92
- 52 Week High
- EBS $13.41
- GEVO $2.98
- Technical
- Relative Strength Index (RSI)
- EBS 57.23
- GEVO 49.00
- Support Level
- EBS $9.02
- GEVO $1.83
- Resistance Level
- EBS $10.29
- GEVO $2.04
- Average True Range (ATR)
- EBS 0.58
- GEVO 0.15
- MACD
- EBS -0.03
- GEVO -0.01
- Stochastic Oscillator
- EBS 93.69
- GEVO 55.68
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.